Posttransfusion purpura with antibodies against human platelet antigen-4a following checkpoint inhibitor therapy: a case report and review of the literature

Transfusion ◽  
2018 ◽  
Vol 58 (10) ◽  
pp. 2265-2269 ◽  
Author(s):  
Khoan Vu ◽  
Andrew D. Leavitt

2013 ◽  
Vol 2013 ◽  
pp. 1-3 ◽  
Author(s):  
O. P. Arewa ◽  
S. Nahirniak ◽  
G. Clarke

Posttransfusion purpura (PTP) is an uncommon, but potentially fatal, transfusion reaction characterized by profound thrombocytopenia and bleeding. PTP is caused by alloimmunization to human platelet specific antigens following blood component transfusion. Although there is evidence of a wide serological spectrum of culprit antibodies implicated, Anti-human-platelet-antigen- (HPA-) 1a is the most common antibody in cases reported. We report a case of posttransfusion purpura in an African American. The patient was negative for HPA-1a antibodies, but anti-HPA-1b was identified with a platelet phenotype of HPA-1a/HPA-1a. Although less common, HPA-1b antibody may be an important consideration in posttransfusion purpura diagnosed in patients of African descent.



2019 ◽  
Vol 80 ◽  
pp. 59
Author(s):  
Justin Kreuter ◽  
Micah Zuccarelli ◽  
Patti Duellman ◽  
Laurie L. Wakefield ◽  
Manish J. Gandhi


Transfusion ◽  
2020 ◽  
Vol 60 (10) ◽  
pp. 2185-2188
Author(s):  
Winnifred French ◽  
Matthew Hopkins ◽  
Anthony Poles ◽  
Aleksandar Mijovic






2017 ◽  
Vol 22 (6) ◽  
pp. 749-753 ◽  
Author(s):  
Simon Bossart ◽  
Selina Thurneysen ◽  
Elisabeth Rushing ◽  
Karl Frontzek ◽  
Henning Leske ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document